BridgeBio Pharma Inc (BBIO)
30.10
-0.94
(-3.04%)
USD |
NASDAQ |
May 17, 16:00
30.10
0.00 (0.00%)
After-Hours: 20:00
BridgeBio Pharma Free Cash Flow: -605.72M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | -605.72M |
| December 31, 2023 | -529.03M |
| September 30, 2023 | -497.82M |
| June 30, 2023 | -488.08M |
| March 31, 2023 | -408.66M |
| December 31, 2022 | -425.82M |
| September 30, 2022 | -468.20M |
| June 30, 2022 | -495.30M |
| March 31, 2022 | -554.95M |
| December 31, 2021 | -546.18M |
| September 30, 2021 | -508.16M |
| Date | Value |
|---|---|
| June 30, 2021 | -477.37M |
| March 31, 2021 | -471.56M |
| December 31, 2020 | -407.23M |
| September 30, 2020 | -384.28M |
| June 30, 2020 | -302.42M |
| March 31, 2020 | -283.06M |
| December 31, 2019 | -256.22M |
| September 30, 2019 | -227.93M |
| June 30, 2019 | -216.48M |
| March 31, 2019 | -183.26M |
| December 31, 2018 | -154.82M |
Free Cash Flow Range, Past 5 Years
-605.72M
Minimum
Mar 2024
-216.48M
Maximum
Jun 2019
-427.72M
Average
-469.88M
Median
Free Cash Flow Benchmarks
| Pfizer Inc | 5.106B |
| Alnylam Pharmaceuticals Inc | 127.82M |
| Regenxbio Inc | -198.64M |
| ACADIA Pharmaceuticals Inc | 63.71M |
| Biomarin Pharmaceutical Inc | 163.21M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -219.54M |
| Cash from Investing (Quarterly) | 22.75M |
| Cash from Financing (Quarterly) | 279.55M |
| Free Cash Flow Per Share (Quarterly) | -1.237 |
| Free Cash Flow to Equity (Quarterly) | -210.23M |
| Free Cash Flow Yield | -11.89% |